翻訳と辞書 |
Newborn Screening Saves Lives Reauthorization Act of 2013 : ウィキペディア英語版 | Newborn Screening Saves Lives Reauthorization Act of 2013
The Newborn Screening Saves Lives Reauthorization Act of 2013 () is a bill that would amend the Public Health Service Act to reauthorize grant programs and other initiatives to promote expanded screening of newborns and children for heritable disorders.〔 The bill was introduced into the United States House of Representatives during the 113th United States Congress. A companion bill, , was introduced into the United States Senate.〔 ==Background== (詳細はhearing loss using evoked auditory potentials and congenital heart defects using pulse oximetry. Newborn screening started out using simple bacterial inhibition assays to screen for a single disorder, starting with phenylketonuria in the early 1960s. With this testing methodology, newborn screening required one test to detect one condition. As mass spectrometry became more widely available, the technology allowed rapid determination of a number of acylcarnitines and amino acids from a single dried blood spot. This increased the number of conditions that could be detected by newborn screening. Enzyme assays are used to screen for galactosemia and biotinidase deficiency. Immunoassays measure thyroid hormones for the diagnosis of congenital hypothyroidism and 17-hydroxyprogesterone for the diagnosis of congenital adrenal hyperplasia. Molecular techniques are used for the diagnosis of cystic fibrosis and severe combined immunodeficiency. The first newborn screening law, the Newborn Screening Saves Lives Act of 2007 (), was passed in 2008.〔(【引用サイトリンク】url=http://mda.org/advocacy/newborn-screening-saves-lives-reauthorization-act )〕 The law established national standards for newborn screenings.〔
抄文引用元・出典: フリー百科事典『 ウィキペディア(Wikipedia)』 ■ウィキペディアで「Newborn Screening Saves Lives Reauthorization Act of 2013」の詳細全文を読む
スポンサード リンク
翻訳と辞書 : 翻訳のためのインターネットリソース |
Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.
|
|